Jeffrey I. Weitz
Impact in
- Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
- Cardiology and Cardiovascular Medicine top 0.01%
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
- Acute Myocardial Infarction Research
Papers in
-
- Atrial Fibrillation Management and Outcomes 177
- Antiplatelet Therapy and Cardiovascular Diseases 74
- Acute Myocardial Infarction Research 39
-
- Venous Thromboembolism Diagnosis and Management 227
- Co-authors
- John W. Eikelboom (48 shared papers)Jack Hirsh (43 shared papers)James C. Fredenburgh (73 shared papers)Harry R. Büller (32 shared papers)Robert P. Giugliano (13 shared papers)Eugene Braunwald (8 shared papers)Elliott M. Antman (7 shared papers)Alan R. Stafford (56 shared papers)
- Journals
- Thrombosis and Haemostasis (64 papers)Journal of Thrombosis and Haemostasis (44 papers)Blood (34 papers)Journal of Biological Chemistry (32 papers)Circulation (29 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Jeffrey I. Weitz
517 papers receiving 44.7k citations
Jeffrey I. Weitz's Hit Papers
Peers
Comparison fields: 5 of 178
- Internal Medicine 18.1k
- Cardiology and Cardiovascular Medicine 22.4k
- Hematology 7.9k
- Genetics 2.7k
- Emergency Medical Services 1.4k
Countries citing papers authored by Jeffrey I. Weitz
This map shows the geographic impact of Jeffrey I. Weitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey I. Weitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey I. Weitz more than expected).
Fields of papers citing papers by Jeffrey I. Weitz
This network shows the impact of papers produced by Jeffrey I. Weitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey I. Weitz. The network helps show where Jeffrey I. Weitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey I. Weitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 530 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Edoxaban versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2013 | 3688 |
| 2 | Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Hit paper breakdown → | 2013 | 3367 |
| 3 | Oral Apixaban for the Treatment of Acute Venous Thromboembolism Hit paper breakdown → | 2013 | 1675 |
| 4 | Low-Molecular-Weight Heparins Hit paper breakdown → | 1997 | 1174 |
| 5 | Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Hit paper breakdown → | 2017 | 1090 |
| 6 | Idarucizumab for Dabigatran Reversal Hit paper breakdown → | 2015 | 986 |
| 7 | Apixaban for Extended Treatment of Venous Thromboembolism Hit paper breakdown → | 2012 | 933 |
| 8 | Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Hit paper breakdown → | 1990 | 904 |
| 9 | A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis Hit paper breakdown → | 1996 | 872 |
| 10 | Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events Hit paper breakdown → | 2002 | 784 |
| 11 | Parenteral Anticoagulants Hit paper breakdown → | 2012 | 736 |
| 12 | Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review Hit paper breakdown → | 1996 | 649 |
| 13 | Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism Hit paper breakdown → | 2003 | 546 |
| 14 | Parenteral Anticoagulants Hit paper breakdown → | 2008 | 521 |
| 15 | Accuracy of clinical assessment of deep-vein thrombosis Hit paper breakdown → | 1995 | 517 |
| 16 | Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Hit paper breakdown → | 2017 | 509 |
| 17 | 2004 | 468 | |
| 18 | Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Hit paper breakdown → | 2014 | 465 |
| 19 | Medical device‐induced thrombosis: what causes it and how can we prevent it? Hit paper breakdown → | 2015 | 440 |
| 20 | Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients Hit paper breakdown → | 2011 | 405 |
About Jeffrey I. Weitz
Jeffrey I. Weitz is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Hematology, Surgery and Genetics, having authored 530 papers that have together received 46.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (227 papers), Atrial Fibrillation Management and Outcomes (177 papers), Blood Coagulation and Thrombosis Mechanisms (143 papers), Antiplatelet Therapy and Cardiovascular Diseases (74 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (49 papers), Blood properties and coagulation (42 papers), Heparin-Induced Thrombocytopenia and Thrombosis (40 papers) and Acute Myocardial Infarction Research (39 papers). The work is most often cited by research in Internal Medicine (18.1k citations), Cardiology and Cardiovascular Medicine (22.4k citations), Hematology (7.9k citations), Genetics (2.7k citations) and Emergency Medical Services (1.4k citations). Jeffrey I. Weitz has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include John W. Eikelboom, Jack Hirsh, James C. Fredenburgh, Harry R. Büller, Robert P. Giugliano, Eugene Braunwald, Elliott M. Antman, Alan R. Stafford, M Samama and Gary E. Raskob. Their work appears in journals such as Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Blood, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.